← Back to timeline

2026-10-19CORP ACTION

Vivos Therapeutics, Inc. [VVOS] - Convertible Preferred Issuance

Vivos Therapeutics, Inc. is issuing convertible preferred stock that ranks pari passu with its Series A Convertible Preferred Stock and Series B Non-Convertible Preferred Stock, with no mandatory or cumulative dividends, and participation in dividends declared on Common Stock on an as-converted basis.

View source filing ↗

Why this matters

Generating analysis…